Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Natural Cytotoxicity Receptors in Health and Disease
Alexander D. Barrow, Claudia Martín, Marco Colonna
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 290

Showing 1-25 of 290 citing articles:

Exploring the NK cell platform for cancer immunotherapy
Jacob A. Myers, Jeffrey S. Miller
Nature Reviews Clinical Oncology (2020) Vol. 18, Iss. 2, pp. 85-100
Open Access | Times Cited: 920
Natural killer cells in cancer biology and therapy
Song‐Yang Wu, Tong‐Ming Fu, Yi‐Zhou Jiang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 626
NK cell-based cancer immunotherapy: from basic biology to clinical development
Sizhe Liu, Vasiliy Galat, Yekaterina Galat, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 492
The NK cell–cancer cycle: advances and new challenges in NK cell–based immunotherapies
Tobias Bald, Matthew F. Krummel, Mark J. Smyth, et al.
Nature Immunology (2020) Vol. 21, Iss. 8, pp. 835-847
Open Access | Times Cited: 371
Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors
Ombretta Melaiu, Valeria Lucarini, Loredana Cifaldi, et al.
Frontiers in Immunology (2020) Vol. 10
Open Access | Times Cited: 339
Roles of natural killer cells in immunity to cancer, and applications to immunotherapy
Natalie K. Wolf, Djem Kissiov, David H. Raulet
Nature reviews. Immunology (2022) Vol. 23, Iss. 2, pp. 90-105
Closed Access | Times Cited: 301
NK cells and ILCs in tumor immunotherapy
Simona Sivori, Daniela Pende, Linda Quatrini, et al.
Molecular Aspects of Medicine (2020) Vol. 80, pp. 100870-100870
Open Access | Times Cited: 197
The biology of TREM receptors
Marco Colonna
Nature reviews. Immunology (2023) Vol. 23, Iss. 9, pp. 580-594
Open Access | Times Cited: 185
Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease
Ángela Saéz, Raquel Gómez-Bris, Beatriz Herrero‐Fernández, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7618-7618
Open Access | Times Cited: 134
CAR-NK cells for cancer immunotherapy: from bench to bedside
Leisheng Zhang, Meng Yuan, Xiaoming Feng, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 132
Human NK cells, their receptors and function
Linda Quatrini, Mariella Della Chiesa, Simona Sivori, et al.
European Journal of Immunology (2021) Vol. 51, Iss. 7, pp. 1566-1579
Open Access | Times Cited: 123
Number and function of uterine natural killer cells in recurrent miscarriage and implantation failure: a systematic review and meta-analysis
Ee Von Woon, Orene Greer, Nishel M. Shah, et al.
Human Reproduction Update (2022) Vol. 28, Iss. 4, pp. 548-582
Open Access | Times Cited: 109
Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment
Hailong Tian, Jiangjun Cao, Bowen Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 106
Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
Nina Lamers-Kok, Denise Panella, Anna‐Maria Georgoudaki, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 100
The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells
Sumit Sen Santara, Dian-Jang Lee, Ângela C. Crespo, et al.
Nature (2023) Vol. 616, Iss. 7956, pp. 348-356
Open Access | Times Cited: 93
Single-cell immunology: Past, present, and future
Florent Ginhoux, Adam Yalin, Charles‐Antoine Dutertre, et al.
Immunity (2022) Vol. 55, Iss. 3, pp. 393-404
Open Access | Times Cited: 71
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Qiaofei Liu, Jiayi Li, Huaijin Zheng, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 67
The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy
Yanlin Yu
Cancers (2023) Vol. 15, Iss. 8, pp. 2323-2323
Open Access | Times Cited: 53
NK cell-based tumor immunotherapy
Hao Zhang, Yang Li, Tingting Wang, et al.
Bioactive Materials (2023) Vol. 31, pp. 63-86
Open Access | Times Cited: 46
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 10, pp. 1089-1108
Open Access | Times Cited: 32
Chimeric antigen receptor-based natural killer cell immunotherapy in cancer: from bench to bedside
Beibei Zhang, Mengzhe Yang, Weimin Zhang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 30
Natural Killer Cells and Cytotoxic T Cells: Complementary Partners against Microorganisms and Cancer
Aristo Vojdani, Sadi Köksoy, Elroy Vojdani, et al.
Microorganisms (2024) Vol. 12, Iss. 1, pp. 230-230
Open Access | Times Cited: 22
New Insights on Genes, Gluten, and Immunopathogenesis of Celiac Disease
Valérie Abadie, Arnold Han, Bana Jabrì, et al.
Gastroenterology (2024) Vol. 167, Iss. 1, pp. 4-22
Closed Access | Times Cited: 17
Natural-Killer-Derived Extracellular Vesicles: Immune Sensors and Interactors
Cristina Federici, Eriomina Shahaj, Serena Cecchetti, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 122
Obesity-Associated Alterations of Natural Killer Cells and Immunosurveillance of Cancer
Ina Bähr, Julia Spielmann, Dagmar Quandt, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 82
Page 1 - Next Page

Scroll to top